These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 28847655

  • 1. Long-Acting β2-Agonists and Risk of Hypertensive Disorders of Pregnancy: A Cohort Study.
    Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Rey E.
    J Allergy Clin Immunol Pract; 2018; 6(2):555-561.e2. PubMed ID: 28847655
    [Abstract] [Full Text] [Related]

  • 2. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S, Forget A, Beauchesne MF, Blais L.
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [Abstract] [Full Text] [Related]

  • 3. Use of short-acting beta2-agonists during pregnancy and the risk of pregnancy-induced hypertension.
    Martel MJ, Rey E, Beauchesne MF, Perreault S, Forget A, Maghni K, Lefebvre G, Blais L.
    J Allergy Clin Immunol; 2007 Mar; 119(3):576-82. PubMed ID: 17166573
    [Abstract] [Full Text] [Related]

  • 4. Beta2-agonists use during pregnancy and the risk of congenital malformations.
    Eltonsy S, Forget A, Blais L.
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
    [Abstract] [Full Text] [Related]

  • 5. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK, Hartzema AG, Winterstein AG, Segal R, Lu X, Hendeles L.
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [Abstract] [Full Text] [Related]

  • 6. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study.
    Barrett PM, McCarthy FP, Evans M, Kublickas M, Perry IJ, Stenvinkel P, Khashan AS, Kublickiene K.
    PLoS Med; 2020 Aug; 17(8):e1003255. PubMed ID: 32797043
    [Abstract] [Full Text] [Related]

  • 7. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB.
    Arch Intern Med; 2012 Oct 08; 172(18):1365-75. PubMed ID: 22928176
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
    Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey E, Blais L.
    Ann Allergy Asthma Immunol; 2014 May 08; 112(5):459-64. PubMed ID: 24656659
    [Abstract] [Full Text] [Related]

  • 10. Impact of maternal use of asthma-controller therapy on perinatal outcomes.
    Cossette B, Forget A, Beauchesne MF, Rey É, Lemière C, Larivée P, Battista MC, Blais L.
    Thorax; 2013 Aug 08; 68(8):724-30. PubMed ID: 23585516
    [Abstract] [Full Text] [Related]

  • 11. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410
    [Abstract] [Full Text] [Related]

  • 12. Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.
    Huang C, Li J, Qin G, Liew Z, Hu J, László KD, Tao F, Obel C, Olsen J, Yu Y.
    PLoS Med; 2021 Sep 19; 18(9):e1003805. PubMed ID: 34582464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L, Sugar EA, Blake K, Castro M, Dimango E, Hanania NA, Happel KI, Peters SP, Reibman J, Saams J, Teague WG, Wise RA, Holbrook JT, American Lung Association Airways Clinical Research Centers.
    J Allergy Clin Immunol Pract; 2018 Sep 19; 6(2):633-643.e1. PubMed ID: 28974349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.
    JAMA; 2014 Sep 17; 312(11):1114-21. PubMed ID: 25226477
    [Abstract] [Full Text] [Related]

  • 20. Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy.
    Blais L, Firoozi F, Kettani FZ, Ducharme FM, Lemière C, Beauchesne MF, Bérard A.
    Pharmacotherapy; 2012 Mar 17; 32(3):202-9. PubMed ID: 22392453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.